TrumpRx is a hot topic today, especially in the context of its foundational concept: direct-to-consumer (DTC) or direct-to-patient (DTP) drug purchase and dispensing. Apparently set to launch, after the Department of Health and Human Services (HHS) issued a guidance that Secretary Robert F. Kennedy, Jr, said,  “makes clear that manufacturers can offer lower-cost drugs directly … Continue reading What TrumpRx Is, What It Is not, and Concerns for Biosimilars